RNS Number : 9334Y Genus PLC 28 February 2025 28 February 2025 Genus plc Director/PDMR Shareholding Genus plc (LSE: GNS) announces that further to the vesting on 28 February 2025 of 44,933 nil-cost options granted on 2 May 2023 over ordinary shares pursuant to Listing Rule 9.4.2R, as listed in table A below, Jorgen Kokke, Chief Executive Officer, sold 19,967 ordinary shares in Genus on 28 February 2025 on the London Stock Exchange to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of 24,966 ordinary shares. The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 28 February 2025. For further information please contact: Genus: Cara Guedeney, Deputy Company Secretary                                  Tel: +44 (0)1256 347100 Table A - Exercise of buy-out awards vesting on 28 February 2025 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHUWUORVBUUUAR